Orbital inflammatory disease after pamidronate treatment for metastatic prostate cancer

Arch Ophthalmol. 2003 Sep;121(9):1335-6. doi: 10.1001/archopht.121.9.1335.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Anti-Inflammatory Agents / therapeutic use
  • Antineoplastic Agents / adverse effects*
  • Bone Neoplasms / drug therapy*
  • Bone Neoplasms / secondary*
  • Diphosphonates / adverse effects*
  • Humans
  • Male
  • Middle Aged
  • Orbital Pseudotumor / chemically induced*
  • Orbital Pseudotumor / drug therapy
  • Pamidronate
  • Prednisone / therapeutic use
  • Prostatic Neoplasms / pathology*

Substances

  • Anti-Inflammatory Agents
  • Antineoplastic Agents
  • Diphosphonates
  • Pamidronate
  • Prednisone